Invesco Ltd. Immunovant, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Immunovant, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 594,242 shares of IMVT stock, worth $16.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

594,242

Previous 570,898 4.09%

Holding current value

$16.3 Million

Previous $15.1 Million 8.47%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.51 - $27.51 $642,193 - $642,193	23,344 Added 4.09%	594,242 $16.3 Million
Q2 2024 Aug 13, 2024	BUY	$25.1 - $31.61 $1.12 Million - $1.41 Million	44,665 Added 8.49%	570,898 $15.1 Million
Q1 2024 May 14, 2024	BUY	$30.27 - $43.79 $1.03 Million - $1.49 Million	34,118 Added 6.93%	526,233 $17 Million
Q4 2023 Feb 12, 2024	BUY	$31.31 - $44.19 $7.92 Million - $11.2 Million	253,060 Added 105.86%	492,115 $20.7 Million
Q3 2023 Nov 13, 2023	BUY	$18.55 - $39.96 $4.02 Million - $8.65 Million	216,455 Added 957.77%	239,055 $9.18 Million
Q2 2023 Aug 11, 2023	BUY	$14.2 - $23.75 $93,194 - $155,871	6,563 Added 40.92%	22,600 $428,000
Q1 2023 May 12, 2023	SELL	$15.27 - $19.72 $12,597 - $16,268	-825 Reduced 4.89%	16,037 $248,000
Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $5,456 - $14,697	828 Added 5.16%	16,862 $299,000
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $821 - $1,331	-209 Reduced 1.29%	16,034 $89,000
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.65 $8,304 - $13,882	-2,457 Reduced 13.14%	16,243 $63,000
Q1 2022 May 16, 2022	BUY	$5.06 - $8.77 $3,597 - $6,235	711 Added 3.95%	18,700 $103,000
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $21,513 - $27,354	-2,935 Reduced 14.03%	17,989 $153,000
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $5.9 Million - $9.56 Million	-841,089 Reduced 97.57%	20,924 $182,000
Q2 2021 Aug 17, 2021	BUY	$9.4 - $16.85 $20,219 - $36,244	2,151 Added 0.25%	862,013 $9.11 Million
Q1 2021 May 17, 2021	SELL	$13.08 - $49.6 $3.5 Million - $13.3 Million	-267,625 Reduced 23.74%	859,862 $13.8 Million
Q4 2020 Feb 16, 2021	BUY	$36.36 - $52.71 $32.1 Million - $46.5 Million	882,862 Added 360.9%	1,127,487 $52.1 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $2.14 Million - $3.69 Million	94,776 Added 63.25%	244,625 $8.61 Million
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $2.08 Million - $4.26 Million	149,849 New	149,849 $3.65 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account